Clinical Trials in Chicago

Showing 4661-4680 of 20,493 trials

Improve PAD PERformance With METformin

NCT03054519

The PERMET trial will determine whether metformin daily for six months improves six-minute walk performance in individuals with peripheral artery disease compared to placebo.

Peripheral Artery Disease

Northwestern University203 participantsStarted May 2017

Gainesville, Florida, United States • Chicago, Illinois, United States • Chicago, Illinois, United States +2 more locations

Enrolling By Invitation2.2 miles

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

NCT05704309

The DPPOS AD/ADRD project will address the overarching question: What are the determinants and the nature of cognitive impairment among persons with pre-diabetes (PreD) and type 2 diabetes (T2D), who are a high-risk group for cognitive impairment and represent a large fraction of the United States (US) population? This U19 proposal addresses the National Alzheimer's Project Act goal to "prevent, halt, or reverse AD" in the high-risk group of persons with pre-diabetes and type 2 diabetes, who represent over half of the population aged 60 years and older in the US.

DiabetesAlzheimer DiseaseDementia, Vascular+2 more

Marinella Temprosa1,976 participantsStarted Nov 2022

Phoenix, Arizona, United States • Alhambra, California, United States • San Diego, California, United States +24 more locations

Improve PAD PERformance With METformin

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Find Trials by Condition in Chicago

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML

A Clinical Study on Acuris™ - Conometric Concept for Single Tooth Restoration

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)

A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Quality Improvement and Practice Based Research in Neurology Using the EMR

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

Beating Heart Mitral Valve Repair With the HARPOON™ System

Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens

Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma

Study of Uterine Prolapse Procedures - Randomized Trial

HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study

Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year